10 results
424B5
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
Prospectus supplement for primary offering
7:00am
the shares. If any of our shareholders were to bring a lawsuit of this type against us, even if the lawsuit is without merit, we could incur substantial … costs defending the lawsuit. The lawsuit could also divert the time and attention of our management, which could harm our business.
Sales
424B5
PROK
ProKidney Corp - Ordinary Shares
10 Jun 24
Prospectus supplement for primary offering
5:13pm
that issued the shares. If any of our shareholders were to bring a lawsuit of this type against us, even if the lawsuit is without merit, we could incur … substantial costs defending the lawsuit. The lawsuit could also divert the time and attention of our management, which could harm our business.
Sales
8-K/A
EX-10.1
PROK
ProKidney Corp - Ordinary Shares
18 Mar 24
Departure of Directors or Certain Officers
4:09pm
based on any claim, cause of action, demand, lawsuit or similar that is waived pursuant to this Agreement and brought by Executive or on his behalf … claim covered by the above waiver and release language, provided however, that this provision will not apply if Executive files a lawsuit challenging
8-K/A
EX-10.2
PROK
ProKidney Corp - Ordinary Shares
18 Mar 24
Departure of Directors or Certain Officers
4:05pm
personal relief based on any claim, cause of action, demand, lawsuit or similar that is waived pursuant to this Agreement and brought by Executive … a lawsuit challenging the validity of this Agreement under any federal, state or local statute, regulation or law, including without limitation, the federal
424B5
PROK
ProKidney Corp - Ordinary Shares
19 Jan 24
Prospectus supplement for primary offering
4:16pm
the shares. If any of our shareholders were to bring a lawsuit of this type against us, even if the lawsuit is without merit, we could incur substantial … costs defending the lawsuit. The lawsuit could also divert the time and attention of our management, which could harm our business.
Sales of additional
8-K
83ncqb19 nb
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFA14A
b2tu90b n883u
21 Jan 22
Additional proxy soliciting materials
4:38pm
8-K/A
EX-2.1
tmbf9v5a2dggaagj aqq
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
- Prev
- 1
- Next